JPH03849B2 - - Google Patents

Info

Publication number
JPH03849B2
JPH03849B2 JP60224617A JP22461785A JPH03849B2 JP H03849 B2 JPH03849 B2 JP H03849B2 JP 60224617 A JP60224617 A JP 60224617A JP 22461785 A JP22461785 A JP 22461785A JP H03849 B2 JPH03849 B2 JP H03849B2
Authority
JP
Japan
Prior art keywords
piroxicam
volume
solution
solvent
methylglucamine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
JP60224617A
Other languages
English (en)
Japanese (ja)
Other versions
JPS6191116A (ja
Inventor
Furiizu Uarutaa
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
HAINRITSUHI MATSUKU NATSUKU
Original Assignee
HAINRITSUHI MATSUKU NATSUKU
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by HAINRITSUHI MATSUKU NATSUKU filed Critical HAINRITSUHI MATSUKU NATSUKU
Publication of JPS6191116A publication Critical patent/JPS6191116A/ja
Publication of JPH03849B2 publication Critical patent/JPH03849B2/ja
Granted legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0019Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Rheumatology (AREA)
  • Organic Chemistry (AREA)
  • Pain & Pain Management (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Peptides Or Proteins (AREA)
  • Finger-Pressure Massage (AREA)
JP60224617A 1984-10-10 1985-10-08 安定化された注射用ピロキシカム液剤 Granted JPS6191116A (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE3437232.6 1984-10-10
DE19843437232 DE3437232A1 (de) 1984-10-10 1984-10-10 Stabilisierte injektionsloesungen von piroxicam

Publications (2)

Publication Number Publication Date
JPS6191116A JPS6191116A (ja) 1986-05-09
JPH03849B2 true JPH03849B2 (forum.php) 1991-01-09

Family

ID=6247603

Family Applications (1)

Application Number Title Priority Date Filing Date
JP60224617A Granted JPS6191116A (ja) 1984-10-10 1985-10-08 安定化された注射用ピロキシカム液剤

Country Status (22)

Country Link
US (1) US4628053A (forum.php)
EP (1) EP0177870B1 (forum.php)
JP (1) JPS6191116A (forum.php)
KR (1) KR890001001B1 (forum.php)
CN (1) CN85107838B (forum.php)
AT (1) ATE62416T1 (forum.php)
AU (1) AU557184B2 (forum.php)
CA (1) CA1251734A (forum.php)
DD (1) DD238329A5 (forum.php)
DE (2) DE3437232A1 (forum.php)
DK (1) DK165901C (forum.php)
FI (1) FI84315C (forum.php)
GR (1) GR852439B (forum.php)
HU (1) HU195111B (forum.php)
IE (1) IE58267B1 (forum.php)
IL (1) IL76624A0 (forum.php)
NO (1) NO166687C (forum.php)
NZ (1) NZ213758A (forum.php)
PH (1) PH23058A (forum.php)
PT (1) PT81264B (forum.php)
SU (1) SU1482509A3 (forum.php)
ZA (1) ZA857783B (forum.php)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2545910B1 (fr) * 1983-05-11 1988-07-22 Valeo Dispositif pour ameliorer l'efficacite d'un echangeur de chaleur dans un boitier d'une installation de climatisation, et boitier de cette installation
IT1196307B (it) * 1984-10-22 1988-11-16 Chiesi Farma Spa Formulazioni farmaceutiche acquose di piroxicam monoidrato
US5807568A (en) * 1994-12-27 1998-09-15 Mcneil-Ppc, Inc. Enhanced delivery of topical compositions containing flurbiprofen
IT1283252B1 (it) * 1996-03-15 1998-04-16 Pulitzer Italiana Soluzioni di piroxicam iniettabili per via parenterale
WO1998001138A1 (fr) * 1996-07-04 1998-01-15 Nippon Kayaku Kabushiki Kaisha Injections de succinate sodique de methylprednisolone
US6136799A (en) * 1998-04-08 2000-10-24 Abbott Laboratories Cosolvent formulations
DE10030345A1 (de) * 2000-06-20 2002-01-10 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen
US20020035107A1 (en) 2000-06-20 2002-03-21 Stefan Henke Highly concentrated stable meloxicam solutions
DE10161077A1 (de) * 2001-12-12 2003-06-18 Boehringer Ingelheim Vetmed Hochkonzentrierte stabile Meloxicamlösungen zur nadellosen Injektion
US8992980B2 (en) 2002-10-25 2015-03-31 Boehringer Ingelheim Vetmedica Gmbh Water-soluble meloxicam granules
US8314124B2 (en) * 2004-02-06 2012-11-20 Active Biotech Ab Crystalline salts of quinoline compounds and methods for preparing them
EP1568369A1 (en) * 2004-02-23 2005-08-31 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the treatment of respiratory diseases in pigs
DE102004021281A1 (de) * 2004-04-29 2005-11-24 Boehringer Ingelheim Vetmedica Gmbh Verwendung von Meloxicam-Formulierungen in der Veterinärmedizin
DE102004030409A1 (de) * 2004-06-23 2006-01-26 Boehringer Ingelheim Vetmedica Gmbh Neue Verwendung von Meloxicam in der Veterinärmedizin
NZ567627A (en) * 2005-09-30 2011-08-26 Boehringer Ingelheim Vetmed Granulation process for making a divisible tablet containing meloxicam
JP5832716B2 (ja) * 2005-10-19 2015-12-16 テバ ファーマシューティカル インダストリーズ リミティド ラキニモドナトリウムの結晶,及びその製造方法
BRPI0713694A2 (pt) * 2006-06-12 2012-10-30 Teva Pharma composição farmacêutica, processo para preparar composição farmacêutica, embalagens vedada, métodos para tratar um indivìduo afligido com uma forma de esclerose múltipla, e para aliviar um sintoma de esclerose múltipla em um indivìduo afligido com uma forma de esclerose múltipla, e, uso da composição farmacêutica
PT2682120T (pt) 2007-12-20 2016-11-07 Teva Pharma Preparações de laquinimod estáveis
ES2633658T3 (es) * 2008-09-03 2017-09-22 Teva Pharmaceutical Industries Ltd. Moduladores 2-oxo-1,2-dihidro-quinolina de la función inmunitaria
JP5359333B2 (ja) * 2009-02-05 2013-12-04 ゼリア新薬工業株式会社 コロソリン酸含有水性液剤
KR20160148050A (ko) * 2009-07-30 2016-12-23 테바 파마슈티컬 인더스트리즈 리미티드 라퀴니모드를 이용한 크론병의 치료
EP3064206B1 (en) * 2009-08-10 2019-03-20 Active Biotech AB Treatment of huntington's disease using laquinimod
CN102647971B (zh) 2009-10-12 2016-03-16 贝林格尔.英格海姆维特梅迪卡有限公司 用于包含美洛昔康的组合物的容器
WO2011107150A1 (en) 2010-03-03 2011-09-09 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long-term treatment of musculoskeletal disorders in cats
US20110218191A1 (en) * 2010-03-03 2011-09-08 Boehringer Ingelheim Vetmedica Gmbh Use of meloxicam for the long term-treatment of kidney disorders in cats
DE102010014290A1 (de) * 2010-04-08 2011-10-13 Hans Otto Meyer zu Spelbrink Mittel zur prophylaktischen und therapeutischen Behandlung von Herpes-Infektionen
US9795568B2 (en) 2010-05-05 2017-10-24 Boehringer Ingelheim Vetmedica Gmbh Low concentration meloxicam tablets
AU2012322706A1 (en) 2011-10-12 2014-05-22 Teva Pharmaceutical Industries Ltd. Treatment of multiple sclerosis with combination of laquinimod and fingolimod
BR112014018485A8 (pt) 2012-02-03 2017-07-11 Teva Pharma Uso de laquinimod para tratar pacientes com a doença de crohn que falharam com a primeira linha de terapia anti-tnf
TW201400117A (zh) 2012-06-05 2014-01-01 Teva Pharma 使用拉喹莫德治療眼發炎疾病
CN104955522A (zh) 2012-11-07 2015-09-30 梯瓦制药工业有限公司 拉喹莫德胺盐
US9233927B2 (en) 2013-03-14 2016-01-12 Teva Pharmaceutical Industries, Ltd. Crystals of laquinimod sodium and improved process for the manufacture thereof
KR101749425B1 (ko) * 2015-11-17 2017-06-22 연세대학교 산학협력단 난용성 약물의 서방형 제제
PL3664800T3 (pl) * 2017-08-09 2024-11-18 Dechra Veterinary Products, Llc Preparaty terapeutyczne zawierające inhibitor cox-2 i ich zastosowania

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE629650A (forum.php) * 1967-05-18 1900-01-01
US3591584A (en) * 1968-08-27 1971-07-06 Pfizer Benzothiazine dioxides
DE2602363C2 (de) * 1976-01-22 1984-04-12 Bayer Ag, 5090 Leverkusen Wäßrige, injizierbare Niclofolan- Formulierungen
DE2756113A1 (de) * 1977-12-16 1979-06-21 Thomae Gmbh Dr K Neue 4-hydroxy-2h-1,2-benzothiazin- 3-carboxamid-1,1-dioxide, verfahren zu ihrer herstellung und diese enthaltende arzneimittel
DE3217315C2 (de) * 1982-05-08 1986-05-22 Gödecke AG, 1000 Berlin Arzneimittelzubereitungen mit einem Gehalt an Oxicam-Derivaten
AT376879B (de) * 1982-10-27 1985-01-10 Gerot Pharmazeutika Verfahren zur herstellung einer injektionsloesung

Also Published As

Publication number Publication date
GR852439B (forum.php) 1986-02-10
EP0177870A2 (de) 1986-04-16
FI853926L (fi) 1986-04-11
DK165901B (da) 1993-02-08
AU557184B2 (en) 1986-12-11
JPS6191116A (ja) 1986-05-09
EP0177870B1 (de) 1991-04-10
HUT38541A (en) 1986-06-30
NO166687B (no) 1991-05-21
CN85107838A (zh) 1986-07-09
NO854011L (no) 1986-04-11
CA1251734A (en) 1989-03-28
ATE62416T1 (de) 1991-04-15
KR890001001B1 (ko) 1989-04-18
HU195111B (en) 1988-04-28
DE3582468D1 (de) 1991-05-16
DE3437232A1 (de) 1986-04-17
KR860003013A (ko) 1986-05-19
NZ213758A (en) 1988-07-28
PH23058A (en) 1989-03-27
AU4842185A (en) 1986-04-17
DK461385D0 (da) 1985-10-09
FI853926A0 (fi) 1985-10-09
IE58267B1 (en) 1993-08-25
DK165901C (da) 1993-06-28
PT81264A (en) 1985-11-01
US4628053A (en) 1986-12-09
NO166687C (no) 1991-09-04
FI84315B (fi) 1991-08-15
EP0177870A3 (en) 1987-06-03
SU1482509A3 (ru) 1989-05-23
PT81264B (pt) 1988-02-17
CN85107838B (zh) 1988-08-24
DD238329A5 (de) 1986-08-20
ZA857783B (en) 1987-05-27
IE852483L (en) 1986-04-10
DK461385A (da) 1986-04-11
FI84315C (fi) 1991-11-25
IL76624A0 (en) 1986-02-28

Similar Documents

Publication Publication Date Title
JPH03849B2 (forum.php)
CA1177398A (en) Watersoluble derivatives of non-steroidal anti- inflammatory agents and a process for the production thereof
JPS62252749A (ja) 水溶性メグルミン塩及びグルカミン塩、その製造方法並びにこれを含有する医薬組成物
US4942167A (en) Pharmaceutical compositions of piroxicam in aqueous solutions and process for their preparation
WO2004058256A1 (en) Pharmaceutical liquid composition containing pyridone derivative
NZ236332A (en) Aqueous pharmaceutical formulation using methionine as a stabiliser
CZ281142B6 (cs) Roztoky léčiva se zvýšenou stabilitou a bez účinků poškozujících tkáň a způsob jejich přípravy
JPH055810B2 (forum.php)
JPS62103020A (ja) 難溶性薬物の可溶化組成物
PT1609481E (pt) Composições farmacêuticas injectáveis compreendendo diclofenaco de sódio de beta-ciclodextrina e um polissorbato
EP0795329B1 (en) Parenterally injectable piroxicam solutions
WO2000004902A1 (en) Stabilized carvedilol injection solution
JP2010504971A5 (forum.php)
JPH0576929B2 (forum.php)
JP2001163776A (ja) 安定化された液剤
US5034397A (en) Stable, water soluble salt compositions of M-AMSA in 1-methyl-2-pyrrolidinone
KR920006911B1 (ko) 안정한 피록시캄 주사액 조성물 및 그의 제조방법
JPS6146454B2 (forum.php)
AU615245B2 (en) Aqueous formulations containing a piperidinylcyclopentylheptenoic acid derivative
JPS6350355B2 (forum.php)
CN1812794B (zh) 溶液药用组合物
JPS61171421A (ja) 安定なプロスタグランジンe類製剤の製造方法
US5420124A (en) Stable, painless piroxicam potassium injectable composition
JPS6119632B2 (forum.php)
JPS6153267A (ja) 酸化および湿気に抵抗性のプロカテロ−ル誘導体およびその製法